| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 04/17/2003 | US20030073679 Novel metallotexaphyrin derivatives |
| 04/17/2003 | US20030073650 Method and apparatus for inactivation of biological contaminants using photosensitizers |
| 04/17/2003 | US20030073617 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases |
| 04/17/2003 | US20030073615 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases |
| 04/17/2003 | US20030072763 Absorb in the low- energy, ultraviolet, visible, or near-infrared (NIR) region of the electromagnetic spectrum that are used for the phototherapy of tumors and other lesions |
| 04/16/2003 | EP1301211A2 Multifunctional nanodevice platform |
| 04/16/2003 | EP0989865B1 Apparatus and method for preparing radioactive medicines for administration |
| 04/16/2003 | EP0877631B1 Conjugate of albumin and a xanthen dye for differentiating between diseased and healthy tissues |
| 04/15/2003 | US6548542 Vision through photodynamic therapy of the eye |
| 04/15/2003 | US6548242 Process for the sterilization of biological compositions and the product thereby |
| 04/15/2003 | US6548048 Encapsulation gases; medical diagnosis, therapy |
| 04/15/2003 | US6548047 Thermal preactivation of gaseous precursor filled compositions |
| 04/15/2003 | US6548045 Anticancer agents |
| 04/10/2003 | WO2003028640A2 In vivo panning for ligands to radiation-induced molecules |
| 04/10/2003 | WO2003028629A2 Chlorin photosensitizing agents for use in photodynamic therapy |
| 04/10/2003 | WO2003028628A2 Photosensitizing carbamate derivatives |
| 04/10/2003 | WO2002064163A3 Reduction or prevention of pdt related inflammation |
| 04/10/2003 | US20030069618 Method, kit and device for the treatment of cosmetic skin conditions |
| 04/10/2003 | US20030069219 Core modified porphyrins |
| 04/10/2003 | CA2462508A1 Photosensitizing carbamate derivatives |
| 04/10/2003 | CA2462261A1 Chlorin photosensitizing agents for use in photodynamic therapy |
| 04/09/2003 | EP1299154A1 Method and apparatus for ion transport activation |
| 04/09/2003 | EP0850224B1 Radiation-activated cytotoxin therapy |
| 04/09/2003 | CN1104908C Improved vision through photodynamic therapy of eye |
| 04/08/2003 | US6545020 Farnesyl Protein transferase inhibitors with in vivo radiosensitizing properties |
| 04/08/2003 | US6544988 Tyrosine kinase inhibitors |
| 04/08/2003 | US6544955 Method of sensitizing tumor cells with adenovirus E1A |
| 04/03/2003 | WO2003026646A1 Photodynamic porphyrin antimicrobial agents |
| 04/03/2003 | WO2003026618A1 Localized non-invasive biological modulation system |
| 04/03/2003 | WO2003026481A2 Optically-absorbing nanoparticles for enhanced tissue repair |
| 04/03/2003 | WO2002088336A3 Genetically modified yt cell line and use thereof |
| 04/03/2003 | WO2002031492A1 Two-dimensionally quantified image method for distinguishing and quantifying overgrowing tissue or the like |
| 04/03/2003 | US20030065362 Method for genetic immunization |
| 04/03/2003 | US20030065029 Agent for diagnosing and treating malignant tumors |
| 04/03/2003 | US20030064104 Shelf-stable, ready to use; to enhance delivery of active medicants/ingredients of pharmaceuticals, nutraceuticals, dietary supplements, therapeutics, diagnostics |
| 04/03/2003 | US20030062483 Device and method for photoactivation |
| 04/03/2003 | CA2481020A1 Localized non-invasive biological modulation system |
| 04/03/2003 | CA2424813A1 Two-dimensional quantified imaging method for distinguishing and quantifying poliferating tissue from oncogenic heterometaplasia |
| 04/02/2003 | EP1297169A2 Method for transfecting cells using a magnetic field |
| 04/02/2003 | EP1296678A2 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 04/02/2003 | EP0881874B1 Viral inactivation treatment of red blood cells using phthalocyanines and red light |
| 04/02/2003 | CN1407901A Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy |
| 04/02/2003 | CN1407900A Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (MPIF-1) |
| 04/01/2003 | US6541229 Use for better preservation of red blood cells during storage and increased viability in vivo following transfusion |
| 04/01/2003 | US6541039 For use in tumor therapy by hyperthermia |
| 04/01/2003 | US6540922 Has ultrasound emitter located relative to compartment of container holding liquid medium and microbubble emitter relative to compartment; produces water supersaturated with salts to induce biotoxic effects on microorganisms |
| 03/27/2003 | WO2002100478A9 Accelerators for increasing the rate of formation of free radicals and reactive oxygen species |
| 03/27/2003 | WO2002074332A3 Method to enhance the immunogenicity of an antigen |
| 03/27/2003 | US20030060811 Process for treatment of psoriasis |
| 03/27/2003 | US20030060719 Use of 5-aminolevulinic acid or a derivate thereof for photodynamic diagnosis and /or photodynamic therapy |
| 03/27/2003 | US20030060718 Indocyanine green (ICG) compositions and related methods of use |
| 03/27/2003 | US20030060505 Administration of a radioprotective alpha, beta unsaturated aryl sulfone compound to a patient prior to anticancer radiotherapy reduces cytotoxic side effects of radiation on normal cells |
| 03/27/2003 | US20030059940 Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 03/27/2003 | US20030059841 Methods of using bioelastomers |
| 03/27/2003 | US20030059840 Methods of using bioelastomers |
| 03/27/2003 | US20030059785 Detection of markers in nascent proteins |
| 03/27/2003 | US20030059426 Method for inducing selectively suppressed immune response to transplanted tissue or cells |
| 03/27/2003 | US20030059401 Composition and method for causing photodynamic damage to target cells |
| 03/27/2003 | US20030059379 Methods for treating periodontal disease |
| 03/27/2003 | US20030059368 Chelator noncovalently bonded to a stable isotope having a nucleus capable of capturing a neutron and emitting a photon, a counterion and a buffer; measuring glomerular filtration rate and glomerular sieving function in a subject |
| 03/26/2003 | EP1294918A2 Replication deficient adenoviral tnf vector |
| 03/26/2003 | EP0740528B1 Gas microspheres for topical and subcutaneous application |
| 03/25/2003 | US6538106 Compositions and methods for treating infections using analogues of indolicidin |
| 03/25/2003 | US6538026 A composition comprising of a monomer component comprised of at least one alkyl cyanoacrylate and at least one inhibitor, and a second component comprised of a resultant aggregate structure formed from an alkyl cyanoacrylate monomer, an alkyl |
| 03/25/2003 | US6537988 Synergistic methods and compositions for treating cancer |
| 03/25/2003 | US6537814 Compositions and methods for altering the biodistribution of biological agents |
| 03/25/2003 | US6537246 Oxygen delivery agents and uses for the same |
| 03/20/2003 | WO2003022360A2 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 03/20/2003 | WO2003022308A2 Therapeutic insert and therapeutic method |
| 03/20/2003 | WO2003004466A3 Dye-sulfenates for dual phototherapy |
| 03/20/2003 | WO2002096366A3 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
| 03/20/2003 | US20030055307 Devices for detection and therapy of atheromatous plaque |
| 03/20/2003 | US20030055024 Administering in divided doses an effective amount of a vascular damaging agent or a pharmaceutically acceptable salt thereof for production of a vascular damaging effect in a warm-blooded animal such as a human |
| 03/20/2003 | US20030054052 Triterpene compositions and methods for use thereof |
| 03/20/2003 | US20030054027 Charged lipids and uses for the same |
| 03/20/2003 | US20030053949 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 03/19/2003 | EP1292298A1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 03/19/2003 | EP0918504B1 Use of genistein as a preventive agent against ultraviolet radiation induced skin photodamage and cancer |
| 03/19/2003 | CA2358146A1 A method of inhibiting immunologically mediated abortions |
| 03/18/2003 | US6534041 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
| 03/18/2003 | US6534040 Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 03/13/2003 | WO2003020324A2 Methods for sterilizing preparations of digestive enzymes |
| 03/13/2003 | WO2003020309A2 Compound |
| 03/13/2003 | WO2002083097A3 Drug delivery system for hydrophobic drugs |
| 03/13/2003 | WO2002059277A3 Electroactive materials for stimulation of biological activity of stem cells |
| 03/13/2003 | WO2002034708A3 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 03/13/2003 | WO2001097848A3 Vitronectin receptor antagonist pharmaceuticals |
| 03/13/2003 | US20030050297 Administering to a mammal, a low molecular weight antioxidants, mimetics of superoxide dismutase |
| 03/13/2003 | US20030050296 Photodynamic porphyrin antimicrobial agents |
| 03/13/2003 | US20030049809 Irradiating a fluid with ultraviolet radiation; obtain fluid, insert into ultraviolet radiation generating apparatus, agitate fluid, expose to ultravolet radiation source |
| 03/13/2003 | US20030049245 Methods for sterilizing preparations of digestive enzymes |
| 03/13/2003 | US20030049202 Method of using gadolinium neutron capture to treat cancers |
| 03/12/2003 | EP1290017A2 Compositions and methods for delivery of a molecule into a cell |
| 03/12/2003 | EP1289562A2 Novel of preparation hypericin bonded with poly-n-vinylamides |
| 03/12/2003 | EP1289556A2 Phytoestrogenic isoflavone compositions |
| 03/12/2003 | EP1289517A2 Pharmaceutical compositions comprising cannabidiol derivatives |
| 03/12/2003 | EP1289453A1 Electrically conducting nanocomposite materials for biomedical applications |
| 03/12/2003 | EP1131100B1 Therapeutic compositions for metabolic bone disorders or bone metastases comprising a photosensitizer and a bisphosphonate |
| 03/11/2003 | US6530944 Localized delivery of heat and biological imaging materials |
| 03/06/2003 | WO2003018006A1 Porphyrin-zinc oxide complex and use of the same as photosensitive medicament which exitates photodynamic action by radiation and the use thereof in targeted therapy |